Promedior promedior.com


Public list: Pharma Startups (4732) Eye Health (692) Rare Diseases (230)

Promedior is a clinical stage immunotherapy company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis occurs when healthy tissue is replaced with excessive scar tissue, compromising function and ultimately leading to organ failure. Fibrosis is a common feature of several rare diseases as well as more prevalent illnesses such as age related macular degeneration, diabetic nephropathy, nonalcoholic steatohepatitis (NASH), and several types of solid t...Show all

Promedior is a clinical stage immunotherapy company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis occurs when healthy tissue is replaced with excessive scar tissue, compromising function and ultima...Show all

Company (Alive / Active)

Phone: 781-538-4200

Fax: 610-560-1436

101 Hartwell Avenue

Lexington, 02421
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Promedior $64.4M Oct 15, 2012
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Promedior Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors

Ceregene

San Diego, California, United States
AcquiredCeregene is a San Diego-based biotechnology company focused on the development of nervous system growth factors (neurotrophic factors) as treatments for neurodegenerative and retinal disorders using gene transfer for their delivery. The company has established a position in the fields of gene therapy and neurotrophic factors, having launched separate clinical trials in Parkinson's and Alzheimer's disease, enrolling a total of nearly 200 patients, over 100 whom have been administered the gene the...Show allLogin to see details

Lipomics Technologies

West Sacramento, California, United States
AcquiredLipomics provides metabolite profiling, biomarker discovery and metabolism consultation services to industry and academia. Its quantitative profiling assays are used to develop an understanding of metabolism in disease, the effects of drugs or foods on metabolism and for identifying biomarkers for use in clinical trials and as commercial products. Lipomics' expertise in lipid and intermediary metabolism drives its development of research and clinical assays. Its TrueMass Profiling is a suite of ...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods for treating fibrosis using crp antagonists Jun 27, 2008 Feb 06, 2018 Patent
Sap variants and their use Nov 06, 2012 Jan 31, 2017 Patent
Serum amyloid p derivatives and their preparation and use Jun 04, 2010 Mar 29, 2016 Patent
Treatment methods for hypersensitive disorders Mar 10, 2010 Jan 12, 2016 Patent
Methods and compositions useful in the treatment of mucositis Jul 07, 2008 Jul 30, 2013 Patent
See all 11 patents